Table 3.
Primary outcome | Time 1 (pretreatment) | Time 2 (posttreatment) | Time 3 (6 months) | Time 4 (12 months) | ||||||
PHQ-9a | ||||||||||
|
iTAUb vs HLPc | |||||||||
|
|
gd | 0.25 | –0.50 | –0.22 | –0.06 | ||||
|
|
P value | .20 | .01 e | .23 | .73 | ||||
|
|
βf (95% CI) | 1.41 (–0.75 to 3.57) | –3.05 (–5.43 to –0.68) | –1.52 (–3.98 to 0.95) | –0.40 (–2.71 to 1.91) | ||||
|
iTAU vs MPg | |||||||||
|
|
g | –0.17 | 0.47 | 0.24 | –0.01 | ||||
|
|
P value | .36 | .01 | .18 | .96 | ||||
|
|
β (95% CI) | 1.00 (–1.16 to 3.16) | –3.00 (–5.37 to –0.63) | –1.68 (–4.15 to 0.78) | 0.06 (–2.25 to 2.37) | ||||
|
iTAU vs PAPPh | |||||||||
|
|
g | –0.23 | 0.23 | 0.31 | 0.01 | ||||
|
|
P value | .20 | .22 | .10 | .99 | ||||
|
|
β (95% CI) | 1.40 (–0.74 to 3.54) | –1.46 (–3.81 to 0.89) | –2.08 (–4.52 to 0.37) | –0.02 (–2.31 to 2.27) | ||||
|
HLP vs MP | |||||||||
|
|
g | 0.07 | -0.01 | 0.03 | –0.07 | ||||
|
|
P value | .71 | .96 | .90 | .70 | ||||
|
|
β (95% CI) | 0.41 (–1.78 to 2.57) | –0.06 (–2.46 to 2.35) | 0.17 (–2.33 to 2.67) | –0.46 (–2.81 to 1.88) | ||||
|
HLP vs PAPP | |||||||||
|
|
g | 0.00 | –0.25 | 0.09 | –0.06 | ||||
|
|
P value | .99 | .19 | .66 | .75 | ||||
|
|
β (95% CI) | 0.01 (–2.16 to 2.18) | –1.59 (–3.97 to 0.79) | 0.56 (–1.92 to 3.04) | –0.38 (–2.70 to 1.94) | ||||
|
MP vs PAPP | |||||||||
|
|
g | –0.07 | –0.23 | 0.06 | 0.01 | ||||
|
|
P value | .72 | .21 | .76 | .94 | ||||
|
|
β (95% CI) | 0.40 (–1.77 to 2.57) | 1.53 (–0.85 to 3.92) | –0.39 (–2.87 to 2.08) | –0.08 (–2.41 to 2.24) |
aPHQ-9: Patient Health Questionnaire-9 items.
biTAU: improved treatment as usual.
cHLP: healthy lifestyle program.
dg: Hedge’s effect size measure.
eStatistically significant values (P<.05) are shown in italics.
fβ: regression coefficient.
gMP: mindfulness program.
hPAPP: positive affect promotion program.